Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aytu Biopharma Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AYTU
Nasdaq
2834
https://aytubio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aytu Biopharma Inc
Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
- Apr 3rd, 2024 1:00 pm
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
- Apr 3rd, 2024 11:00 am
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript
- Feb 16th, 2024 1:27 pm
Aytu BioPharma Second Quarter 2024 Earnings: Beats Expectations
- Feb 16th, 2024 10:33 am
Q2 2024 Aytu Biopharma Inc Earnings Call
- Feb 15th, 2024 10:49 am
Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter
- Feb 14th, 2024 9:05 pm
Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
- Feb 7th, 2024 9:15 pm
Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
- Jan 23rd, 2024 2:00 pm
When Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?
- Jan 16th, 2024 11:59 am
Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now
- Dec 6th, 2023 12:00 pm
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023
- Nov 30th, 2023 1:00 pm
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call Transcript
- Nov 15th, 2023 2:44 pm
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
- Nov 14th, 2023 9:05 pm
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year
- Nov 8th, 2023 1:30 pm
Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023
- Nov 7th, 2023 9:15 pm
Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
- Oct 26th, 2023 12:00 pm
Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023
- Oct 9th, 2023 8:15 pm
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q4 2023 Earnings Call Transcript
- Sep 28th, 2023 12:18 pm
There's No Escaping Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Muted Revenues
- Sep 28th, 2023 10:06 am
Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023
- Sep 27th, 2023 8:20 pm
Scroll